Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 243

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis

Open access
Miedema, Michael D., Duprez, Daniel A., Misialek, Jeffrey R., Blaha, Michael J., Nasir, Khurram, Silverman, Michael G., Blankstein, Ron, Budoff, Matthew J., Greenland, Philip, Folsom, Aaron R. · 2014 · Circulation: Cardiovascular Quality and Outcomes

Abstract

Background—: Aspirin for the primary prevention of coronary heart disease (CHD) is only recommended for individuals at high risk for CHD although the majority of CHD events occur in individuals who are at low to intermediate risk. Methods and Results—: To estimate the potential of coronary artery calcium (CAC) scoring to guide aspirin use for primary prevention of CHD, we studied 4229 participants from the Multi-Ethnic Study of Atherosclerosis who were not on aspirin at baseline and were free of diabetes mellitus. Using data from median 7.6-year follow-up, 5-year number-needed-to-treat estimations were calculated by applying an 18% relative CHD reduction to the observed event rates. This was contrasted to 5-year number-needed-to-harm estimations based on the risk of major bleeding reported in an aspirin meta-analysis. Results were stratified by a 10% 10-year CHD Framingham Risk Score (FRS). Individuals with CAC≥100 had an estimated net benefit with aspirin regardless of their traditional risk status (estimated 5-year number needed to treat of 173 for individuals <10% FRS and 92 for individuals ≥10% FRS, estimated 5-year number needed to harm of 442 for a major bleed). Conversely, individuals with zero CAC had unfavorable estimations (estimated 5-year number needed to treat of 2036 for individuals <10% FRS and 808 for individuals ≥10% FRS, estimated 5-year number needed to harm of 442 for a major bleed). Sex-specific and age-stratified analyses showed similar results. Conclusions—: For the primary prevention of CHD, Multi-Ethnic Study of Atherosclerosis participants with CAC≥100 had favorable risk/benefit estimations for aspirin use while participants with zero CAC were estimated to receive net harm from aspirin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circoutcomes.113.000690

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 31

  1. 10.1097/HJR.0b013e32832b38a1 · DOI
  2. 10.1016/S0140-6736(09)60503-1 · DOI · Paper page
  3. 10.1001/jama.295.3.306 · DOI · Paper page
  4. 10.1016/j.ahj.2011.04.006 · DOI
  5. 10.1001/archinternmed.2011.628 · DOI · Paper page
  6. 10.1161/01.CIR.88.6.2548 · DOI · Paper page
  7. 10.1016/j.ahj.2012.05.008 · DOI
  8. 10.1016/j.jcmg.2009.03.009 · DOI · Paper page
  9. 10.1016/j.jacc.2011.01.055 · DOI
  10. 10.1001/jama.2010.461 · DOI · Paper page
  11. 10.1001/jama.2012.9624 · DOI · Paper page
  12. 10.1093/aje/kwf113 · DOI · Paper page
  13. 10.1148/radiol.2341040439 · DOI · Paper page
  14. 10.1136/bmj.296.6618.313 · DOI · Paper page
  15. 10.1056/NEJM198907203210301 · DOI · Paper page
  16. 10.1016/S0140-6736(97)11475-1 · DOI · Paper page
  17. 10.1016/S0140-6736(00)03539-X · DOI · Paper page
  18. 10.1161/circoutcomes.110.959239 · DOI
  19. 10.7326/0003-4819-150-6-200903170-00008 · DOI · Paper page
  20. 10.1161/01.cir.0000020190.45892.75 · DOI · Paper page
  21. 10.1001/jama.285.19.2486 · DOI · Paper page
  22. 10.1016/S0140-6736(11)60784-8 · DOI · Paper page
  23. 10.1016/j.jacc.2009.07.018 · DOI
  24. Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. Washington, DC: The National Academies Press; 2009.
  25. 10.1016/j.jacc.2011.12.057 · DOI
  26. 10.1161/circoutcomes.112.965566 · DOI
  27. 10.1161/CIR.0b013e3182051b4c · DOI · Paper page
  28. 10.1161/circimaging.111.964528 · DOI · Paper page
  29. 10.1016/j.jcmg.2008.12.031 · DOI · Paper page
  30. 10.1177/1740774512436882 · DOI
  31. 10.1001/jama.2012.5034 · DOI · Paper page

Cited by

See all 243

Metadata

Authors
Miedema, M. D., Duprez, D. A., Misialek, J. R., Blaha, M. J., Nasir, K., Silverman, M. G., Blankstein, R., Budoff, M. J., Greenland, P., & Folsom, A. R.
Venue
Circulation: Cardiovascular Quality and Outcomes
Published
2014-05
Volume
7
Issue
3
Pages
453-460
ISSN
  • 1941-7705 (ISSN-L)
  • 1941-7713
OpenAlex
W2109960851
Cited by
243
References
10
FWCI
13.48
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis. https://app.cochat.ai/papers/10.1161/circoutcomes.113.000690
The paper
Miedema, M. D., Duprez, D. A., Misialek, J. R., Blaha, M. J., Nasir, K., Silverman, M. G., Blankstein, R., Budoff, M. J., Greenland, P., & Folsom, A. R. (2014). Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis. Circulation: Cardiovascular Quality and Outcomes. https://doi.org/10.1161/circoutcomes.113.000690

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.